Selective reductions in plasma Aβ 1-42 in healthy elderly subjects during longitudinal follow-up: A preliminary report

American Journal of Geriatric Psychiatry

Volumn 13, Issue 10, 2005, Pages 914-917

  Pomara, Nunzio ^a,b   Willoughby, Lisa M ^a   Sidtis, John J ^a,b   Mehta, Pankaj D ^c  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; ELDERLY CARE; FOLLOW UP; GENOTYPE; HUMAN; MINI MENTAL STATE EXAMINATION; SCORING SYSTEM; BLOOD; FEMALE; GENETICS; HEALTH STATUS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST;

AGED; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 33644877175     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/00019442-200510000-00012     Document Type: Article

References (12)

1. Scheuner D, Eckman C, Jensen M, et al: Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 1996; 2:864-870
2. Schupf N, Patel B, Silverman W, et al: Elevated plasma amyloid β-peptide 1-42 and onset of dementia in adults with Down syndrome. Neurosci Lett 2001; 301:199-203
3. Ertekin-Taner N, Graff-Radford N, Younkin LH, et al: Linkage of plasma Aβ 42 to a quantitative locus on Chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 2000; 290:2303-2304
4. Mayeux R, Tang MX, Jacobs DM, et al: Plasma amyloid β-peptide 1-42 and incipient Alzheimer's disease. Ann Neurol 1999; 46:412-416
5. Mayeux R, Honig LS, Tang MX, et al: Plasma Aβ40 and Aβ42 and Alzheimer's disease: relation to age, mortality, and risk. Neurology 2003; 61:1185-1190
6. Chen M, Inestrosa NC, Ross GS, et al: Platelets are the primary source of amyloid β-peptide in human blood. Biochem Biophys Res Commun 1995; 213:96-103
7. Mehta PD, Pirttila T, Mehta SP, et al: Plasma and cerebrospinal fluid levels of amyloid β proteins 1-40 and 1-42 in Alzheimer disease. Arch Neurol 2000; 57:100-105
8. Skoog I, Davidsson P, Aevarsson O, et al: Cerebrospinal fluid β-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds. Dement Geriatr Cogn Disord 2003; 15:169-176
9. Mehta PD, Pirttila T, Patrick BA, et al: Amyloid β protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease. Neurosci Lett 2001; 304:102-106
10. Tanzi RE, Moir RD, Wagner SL: Clearance of Alzheimer's Aβ peptide: the many roads to perdition. Neuron 2004; 43:605-608
11. DeMattos DB, Bales KR, Paul SM, et al: Potential role of endogenous and exogenous Aβ binding molecules in Aβ clearance and metabolism, in Metabolic Regulation of Amyloid Protein and Alzheimer's Disease. Edited by Saido T. Georgetown, Tex, Landes Bioscience, 2003, pp 127-143
12. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG: Age-dependent changes in brain, CSF, and plasma amyloi(beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 2001; 21:372-381